Institutional investors purchased a net $5.1 million shares of MNKD during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 20.75% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREATIVE PLANNING, INC. Bought 34.1 Thousand shares of MannKind Corp
MEEDER ASSET MANAGEMENT, INC. Bought 29.4 Thousand shares of MannKind Corp
CLOUD CAPITAL LLC Bought 3.3 Thousand shares of MannKind Corp